Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 7 - Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
Patents for C07H 7 - Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond (2,294)
09/2010
09/16/2010US20100233207 C-glycolipids with enhanced th-1 profile
09/14/2010CA2472335C Geranyl compounds
09/10/2010WO2009068531A3 Adamantyl o-glucuronide derivatives as inhibitors of dipeptidyl peptidase iv for the treatment of diabetes
09/07/2010CA2451971C Process for producing sugar chain asparagine derivative
09/01/2010CN101817851A Method for synthesizing rare ketohexose and ketoheptose from sugar acid lactone
08/2010
08/26/2010US20100216985 Stable cystal of protected pseudouridine
08/25/2010EP1385857B1 Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation
08/24/2010US7781577 2-[4-Chloro-3-(4-hydroxy-benzyl)-phenyl]-6-methoxy-tetrahydro-pyran-3,4,5-triol; 2-[4-Chloro-3-(4-ethoxy-benzyl)-phenyl]-3,4,5-trihydroxy-piperidine-1-carboxylic acid methyl ester; (2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-methoxytetrahydro-2H-thiopyran-3,4,5-triol; antidibetic, antiobesity agents
08/19/2010US20100210835 Mimetic Drug Delivery Systems for Release with Specific Molecular Triggers
08/12/2010US20100203015 Carba-nucleoside analogs for antiviral treatment
08/11/2010CN101801989A Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors
08/11/2010CN101798327A Preparation process of 2-keto-D-glucolactone
08/10/2010US7772407 (1S)-1,5-anhydro-1-[3-(1-benzothien-2-ylmethyl)phenyl-D-glucitol and derivatives are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity
08/10/2010US7772378 inhibiting sodium-dependent glucose cotransporter SGLT2; diabetes mellitus, metabolic acidosis or ketosis, reactive hypoglycaemia, hyperinsulinaemia, glucose metabolic disorder, insulin resistance, metabolic syndrome, dyslipidaemias, atherosclerosis, obesity, high blood pressure, chronic heart failure
08/10/2010US7772191 Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
08/05/2010DE10247073B4 Verfahren zur Herstellung von monomeren Uronsäuren, insbesondere D-Mannuronsäure und D-Guluronsäure und deren Verwendung als Arzneimittel Process for the preparation of monomeric uronic acids, in particular D-mannuronic acid and D-guluronic acid, and their use as medicaments
07/2010
07/29/2010WO2010063948A3 Novel c-xyloside oxime compounds, and cosmetic use
07/22/2010US20100184710 Therapeutic Bifunctional Compounds
07/13/2010US7754878 Functionalization of natural or synthetic fibers by forming carbon-carbon bonds; improved stability during repeated laundering
07/08/2010WO2010049451A3 C-glycosidic analogues of alpha-galactosylceramids having immunostimulating and immunoregulating properties
07/06/2010US7750145 sodium glucose co-transporter 2 inhibitors; for prevention or treatment of diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications, obesity
07/01/2010WO2010052314A3 C-glycoside compounds, and method for preparing c-glycoside compounds
07/01/2010US20100167988 Ethoxyphenylmethyl inhibitors of sglt2
06/2010
06/29/2010US7745417 1,2-dihydro-2-pyridinone substituted with biotin, bromine or iodine photoreactive group, fluorescent molecule; artificial base pairs; aptamers, antisense agents, ribozymes
06/23/2010CN101754972A Crystal structures of SGLT2 inhibitors and processes for preparing same
06/22/2010US7741294 Non-standard nucleobases implementing the isocytidine and isoguanosine hydrogen bonding patterns
06/22/2010US7741289 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
06/17/2010WO2010067036A1 Novel aryl c-xyloside compounds, and cosmetic use
06/17/2010WO2010067010A2 Derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics
06/17/2010WO2010067008A2 Bicyclic derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics
06/17/2010WO2010066970A1 Novel flavour enhancer compounds
06/17/2010CA2746701A1 Bicyclic derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics
06/17/2010CA2746429A1 Derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics
06/15/2010CA2493391C Novel thiophene glycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
06/15/2010CA2350808C Chemiluminescent substrates for neuraminidase, assays for detection of neuraminidase and kits therefor
06/10/2010WO2010063953A2 Novel amino c-xyloside compounds, and cosmetic use
06/10/2010WO2010063948A2 Novel c-xyloside oxime compounds, and cosmetic use
06/10/2010US20100143300 Hepatitis c therapies
06/09/2010CN101723990A Complex salt consisting of glucuronic acid or glucurolactone and kushenin or matrine and application thereof
06/08/2010US7732596 2-( beta -D-Glucopyranosyl)-4-(2-phenylethyl)benzo[b]thiophene; prevention or treatment of a disease associated with hyperglycemia such as diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications or obesity
06/08/2010US7732414 cosmetic make-up removing composition; for treating aging, fibroblasts, keratinocytes; particularly hyaluronic acid, proteoglycans
06/08/2010US7732413 1,4-Diphenyl-3-substituted azetidin-2-ones; can be metabolized in vivo to form a sterol and/or stanol absorption inhibitor and a sterol biosynthesis inhibitor for treatment of atherosclerosis, hypercholesterolemia, or sitosterolemia
06/03/2010US20100137230 New pyridin-2-one compounds
06/02/2010CN101717133A Method for removing pigment in gulonic acid mother solution
06/01/2010US7727965 C-glycosylisoflavones having alkylaminoalkoxyl substituent, preparation and use of the same
05/2010
05/27/2010WO2010059958A2 Artificial lectin mimics and uses thereof
05/27/2010WO2009093821A9 Synthesis of peptide nucleic acids conjugated with amino acids and their application
05/26/2010CN1794999B Remedy for nerve damage
05/20/2010WO2010036407A3 Antiviral nucleoside analogs
05/14/2010WO2010052314A2 C-glycoside compounds, and method for preparing c-glycoside compounds
05/13/2010US20100121040 Therapeutic agent for pain disease
05/13/2010US20100117522 Organic material, film comprising the same and electric device comprising the film
05/12/2010EP2183263A1 Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors
05/12/2010CN1816516B Method for selective carbohydrate oxidation using supported gold catalysts
05/12/2010CN1558911B Synthetic heparin pentasaccharides
05/12/2010CN101704851A Method for preparing zanamivir intermediate serving as compound resisting highly pathogenic avian influenza
05/12/2010CN101041660B 1,2-dihydrogen pyridine derivative, carbon glycosides intermediate and preparation method and application thereof
05/06/2010WO2010049451A2 C-glycosidic analogues of alpha-galactosylceramids having immunostimulating and immunoregulating properties
05/06/2010WO2010029302A3 Compounds for treating viral infections
04/2010
04/27/2010US7704988 N-[3-(4-{(2S,3R)-2-(-(4-{[(2S, 5S, 3R, 4R, 6R)-3,4,5-trihydroxy-6-(hydroxymethyl)perhydro-2H-pyran-2-yl]ethyl-2-yl}phenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-oxoazetidin-1-yl}phenyl)propyl]-N-methylmethanesulfonamide; anticholesterol agent; low density lipoprotein; treating atherosclerosis
04/15/2010US20100093991 Methods for the preparation of 9-deazapurine derivatives
04/13/2010US7696177 N-[3-(4-{(2S,3R)-2-(-(4-{[(2S, 5S, 3R, 4R, 6R)-3,4,5-trihydroxy-6-(hydroxymethyl)perhydro-2H-pyran-2-yl]ethyl-2-yl}phenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-oxoazetidin-1-yl}phenyl)propyl]-N-methylmethanesulfonamide; anticholesterol agent; low density lipoprotein; treating atherosclerosis
04/07/2010EP2172473A1 Alpha, beta-unsaturated, delta-lactones, process for their preparation and their application as pesticides
04/07/2010EP2172457A2 Fredericamycin derivatives
04/07/2010CN101691410A Marine oligosaccharide chromic compound having function of preventing and treating insulin resistance
04/01/2010WO2010036407A2 Antiviral nucleoside analogs
03/2010
03/31/2010EP2168972A2 Preparation and use of carbohydrate-based ring structures with antimicrobial and cytostatic activity
03/31/2010CN101686716A 新颖的益生元 Novel prebiotic
03/30/2010US7687469 Glucopyranosyl-substituted benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
03/24/2010CN101679189A Novel reaction with a gold catalyst
03/23/2010US7683160 1-chloro-4-( beta -D-glucopyranos-1-yl)-2-[4-((1R,2R)-2-hydroxy-cyclopent-1-yloxy)-benzyl]-benzene; metabolic disorders such as diabetes, metabolic acidosis or ketosis, reactive hypoglycaemia, hyperinsulinaemia; sodium-dependent glucose cotransporter SGLT2 inhibitors
03/18/2010WO2010029302A2 Compounds for treating viral infections
03/18/2010US20100069310 1-chloro-4-( beta -D-glucopyranos-1-yl)-2-[4-((1R,2R)-2-hydroxy-cyclopent-1-yloxy)-benzyl]-benzene; metabolic disorders such as diabetes, metabolic acidosis or ketosis, reactive hypoglycaemia, hyperinsulinaemia; sodium-dependent glucose cotransporter SGLT2 inhibitors
03/17/2010CN101671372A Esterification reaction synthetic method of oligomeric propylene diester and oligomeric propylene diester thereof
03/16/2010CA2360069C Protecting groups for carbohydrate synthesis
03/04/2010WO2009138601A3 Use of mannose-6-phosphate for controlling angiogenesis, ligament regeneration, and cartilage reconstruction
03/03/2010EP2157870A1 Novel prebiotics
02/2010
02/23/2010US7666848 such as 3-(4-Methoxy-phenyl)-1-[3-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-thiophen-2-yl]-propan-1-one; for use as antidiabetics
02/18/2010WO2010018834A1 Method for releasing reducing glycan by ammonium salt
02/18/2010WO2009135673A8 Compounds with glycidic structure active in the therapy of systemic and local inflammation
02/16/2010US7662790 Glucopyranosyl-substituted (heteroaryloxy-benzyl)-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
02/04/2010WO2010012153A1 Phlorizin derivatives and their preparation and application
01/2010
01/20/2010EP1611893B1 Remedy for nerve damage
01/20/2010CN101628905A C-aryl glucoside SGLT2 inhibitors and method
01/19/2010CA2641571C Treatment of osteoarthritis
01/12/2010CA2110111C Production of saccharide carboxylic acids
01/07/2010US20100004184 Anti-hypercholesterolemic compounds
01/07/2010US20100004160 Substituted fused heterocyclic c-glycosides
01/06/2010CN101622265A Antiviral compounds
12/2009
12/30/2009WO2009135673A3 Compounds with glycidic structure active in the therapy of systemic and local inflammation
12/24/2009US20090318678 Stable C-Glycoside Sugar and C-Glycoconjugate Mimetics, Method for preparing same and uses Thereof in Particular in Cosmetics and Drugs
12/23/2009WO2009154276A1 Crystal of spiroketal derivative, and process for production thereof
12/23/2009CA2727923A1 Crystal of spiroketal derivatives and process for preparation of spiroketal derivatives
12/10/2009WO2009125017A3 Process for the extraction of mangiferin and isomangiferin
12/10/2009US20090305998 Hsp90 inhibitors
12/10/2009US20090305997 Use of a galactose-derived c-glycoside compound as an agent for activating and regulating cutaneous immunity
12/10/2009US20090304583 Pathological tissue detection and treatment employing targeted benzoindole optical agents
12/09/2009CN101600438A Therapeutic agent for pain disease
12/03/2009US20090299053 Product Resulting From the Grafting of Fatty Chains to Ulvans and Use of Said Product as a Surfactant
12/02/2009EP2125848A1 Antiviral compounds
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 23